CK Xie, CY Liao, HY Lin, YD Wu, FC Lu, XX Huang… - Molecular Cancer, 2024 - Springer
The Nab-paclitaxel combined with gemcitabine (AG) regimen is the main chemotherapy
regimen for pancreatic cancer, but drug resistance often occurs. Currently, the ability to …